The "World Prescription Dermatological Drugs Market, 10th Edition" report, now available from Research and Markets shows the field of dermatology is currently experiencing a busy and interesting period with an expanding range of therapeutic options available to physicians. World Prescription Dermatological Drugs Market takes an inclusive look at many different areas of dermatology and prescription dermatology products.  According to the report, this area of medicine has blossomed due to an increase in skin cancer incidence, new exciting biologics for psoriasis, increased demand by baby boomers—both men and women—for antiaging products, consolidation within the industry, and strong late stage pipeline entities.

The worldwide opportunity for prescription dermatology products is dominated by several key markets, including the United States, Europe, Japan, and rest of world. Penetration within any of the prescription dermatological drugs segments is based on the incidence and prevalence in different regions. Level of demand may be based on any number of factors including epidemiology (i.e., skin color), economic conditions, reimbursement issues, and availability of generic products.

Advancements in technology and knowledge of the disease process are influencing the research and development efforts of the industry, along with the decisions of what products to pursue.

The report finds that demand in the prescription dermatology products market will likely remain high due to the aging population and the quest for lifestyle treatments to meet the needs of aging baby boomers.

There continues to be a shift in the understanding of the pathophysiology of many skin diseases. Some of the most exciting new developments in dermatology include:

• New biologics and their uses in dermatology
• Movement towards dispensing prescription dermatology agents in the office
• Growth in platelet rich plasma